<DOC>
	<DOCNO>NCT01081730</DOCNO>
	<brief_summary>The patient include observational study draw research database contain claim enrollment data member large , geographically diverse US health plan . The objective study estimate rate serious infection , tuberculosis , malignancy , outcome psoriasis patient treat ustekinumab , anti-tumor necrosis factor ( TNF ) biologics , non-anti-TNF biologics , systemic non-biological treatment .</brief_summary>
	<brief_title>Ustekinumab Safety Surveillance Program Using Ingenix NHI Database</brief_title>
	<detailed_description>The participant include study drawn Ingenix Normative Health Informatics Database , proprietary research database contain claim enrollment data date back 1993 member large , geographically diverse US health plan . This study include cohort participant claim consistent diagnosis psoriasis initiate ustekinumab , anti-TNF biologics , non-anti-TNF biologics , systemic non-biological treatment . Participants identify claim bear code dispense drug , procedure diagnose follow launch ustekinumab 8 year . A sample enrol health plan member without claim evidence diagnosis treatment psoriasis also select . The claim database use estimate incidence primary outcomes serious infection , tuberculosis ( TB ) non-TB mycobacterial infection , malignancy lymphoma , select outcome . Potential case study outcome identify claim may confirm medical record review . No study agent administer study . All patient receive standard-of-care treatment prescribed physician .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Ustekinumab</mesh_term>
	<criteria>Complete medical coverage pharmacy benefit Six month continuous enrollment prior date cohort entry Participants exclude information age , gender enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>ustekinumab</keyword>
	<keyword>anti-TNF biologics</keyword>
	<keyword>non-anti-TNF biologics</keyword>
	<keyword>systemic non-biological treatment</keyword>
</DOC>